Digitizing Clinical Trials for Diabetes Research
The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to improved patient experience through the use of wearables and digital tools.

Driving respiratory research with global scale and proven execution
From medical devices to post-market studies and PASS programs, Alcedis brings hands-on experience in conducting complex respiratory trials. With more than 13,000 patients enrolled across 1,000+ sites, we support regional and global studies with digital infrastructure and operational precision.

Global Execution
Successful conduct of respiratory studies across Germany, DACH region, Eastern Europe, and global setups in up to 20 countries

Versatile Study Types
Experience in medical device trials, post-market, and drug studies in real-world settings.

Site Network
More than +1,000 activated sites and over +13,000 patients enrolled across multiple global study setups.
Trust in our Experience
- We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
- Bringing a high level of academic engagement to deliver the full suite of trial related services, unlike any traditional contract model.
Contact Experts

Suitable Technologies
With our strong technological expertise, we are setting new standards in diabetes research with our integrated, patient-centered and data-driven platform.
Discover Technologies
Let's create an impact. Together.
With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of diabetes care.
Contact us